Stage III Verrucous Carcinoma of the Larynx Suspended Phase Trials for DB00002 (Cetuximab)

IndicationStatusPhase
DBCOND0029516 (Stage III Verrucous Carcinoma of the Larynx)SuspendedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02177838Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck CancerTreatment